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ABSTRACT
Nearly a century ago Pavel Cerenkov predicted, and verified, that charged par-
ticles travelling at high velocities trough dielectric media emits light in the UV-
NIR range. As it turns out, several β-emitting radioisotopes produces β-particles
of sufficient energy to induce this Cerenkov emission in tissue like media. In
2009 Cerenkov luminescence imaging (CLI) was proposed as an optical imag-
ing modality, relying on the detection of the Cerenkov radiation emitted from ra-
dioisotopes inside a subject. The technique share a lot similarities with PET, and
it is very common to use PET probes for CLI. Several studies has compared the
two methods and for superficial measurements good agreement has been found.
As most optical methods CLI is however very depth limited and its potential ap-
plications are primarily in a pre-clinical environment.
In this work a forward model for the emission and propagation of Cerenkov radia-
tion from β-emitting isotopes is presented. The model is based on the continuous
slowing down approximation for the interactions of β-particles with the tissue.
The theory of Frank and Tamm is employed for the emission of Cerenkov ra-
diation and the radiative transport equation for the propagation of the Cerenkov
photons.
Based on the forward model an inverse model for the reconstruction of the spatial
distribution of the radioisotope from external measurements is presented. The
inverse model is formulated as an optimization problem, where the difference
between predicted Cerenkov intensity from the forward model and measurements
are minimized. The optimization is performed iteratively using the Levenberg-
Marquardt algorithm.
Validation of the underlying assumptions and approximations is performed by
comparison to Monte Carlo simulations. The performance of the models and their
implementation was assessed through simulations and to some extent experimen-
tal studies. The initial results indicates that the forward model is working as in-
tended. While reconstruction of simulated data produced reasonable results, the
reconstruction of the experimental measurements were mediocre at best.
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POPULÄRVETENSKAPLIG SAMMAN-
FATTNING
Molekylära avbildningsmetoder har gjort det möjlighet att följa biologiska pro-
cesser på molekyl- och cellnivå. SPECT och PET är etablerade tekniker för
molekylär avbildning som används dagligen inom både sjukvård och forskning.
Andra metoder existerar, så som magnetröntgen och ultraljud, men dessa har mer
begränsade tillämpningar inom ämnet och kommer därför inte diskuteras närmare.
I SPECT och PET introduceras ett radioaktivt preparat i objektet som ska avbil-
das och därefter mäter man den högenergetiska gammastrålningen som avges då
det radioaktiva preparatet sönderfaller. Från dessa mätningar beräknar man sedan
preparatets fördelning i objektet. Ofta är man intresserad av att avbilda någon
specifik process eller omårde. I dess fall fäster man ofta preparatet på en molekyl
som söker sig till processen eller området av intresse.
Gemensamt för SPECT och PET är att detektorerna (gammakamerorna) som an-
vänds är stora och relativt dyra, vilket ofta begränsar antalet maskiner på ett in-
stitut. Undersökningen tar också relativt lång tid, ca 15-30 min beroende på vad
som ska avbildas. I de flesta fall är det dessutom endast möjligt att avbilda ett ob-
jekt i taget. Detta tillsammans med ett begränsat antal maskiner innebär en hård
begränsing på antal undersökningar som kan utföras under en viss tid. För forskn-
ingssyften, särskilt vid djurförsök, kan detta vara mycket begränsande. Ofta vill
man följa en stor population och göra mätningar på samtliga individer vid unge-
fär samma tidpunkt. De tidigare nämnda restriktionerna kan alltså innebära en
begränsning för kvalitén på dessa typer av studier.
En möjlighet för att dels komma runt detta problem, men också öppna upp nya
tillämpningar inom molekylär avbildning, är optiska avbildningstekniker. I dagsläget
finns det en uppsjö av optiska metoder under utveckling. Många av dem bygger
på olika principer men de har alla den gemensamma nämmnaren ljus i det ultra-
violetta, synliga och infraröda området. Denna typ av ljus är lätt att mäta jämfört
med gammastrålning, i princip skulle en vanlig digitalkamera kunna användas. I
praktiken används dock något mer sofistikerade kameror då ljuset som ska mätas
ofta är mycket svagt. I många fall är det dessutom möjligt att utföra mätningar på
flera objekt samtidigt. Jämfört med gammastrålningen som används vid SPECT
och PET så har det optiska ljuset dessutom mycket mindre skadlig inverkan på
biologisk vävnad. Dessa fördelar kommer till kostnaden av att det optiska ljuset
inte kan färdas några längre sträckor i vävnad innan det släcks ut. Gammastrål-
ning kan passera genom en hel kropp med liten inverkan på dess riktning och
intensitet. Optiskt ljus kommer snabbt att förlora sin ursprungliga riktning och
dessutom att vara helt utsläckt efter, i bästa fall, bara ett par centimeter.
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En relativt ny optisk metod, den första artikeln som behandlade den publicer-
ades 2009, är Cerenkov luminiscens avbildning (Cerenkov luminescence imaging
på engelska). Metoden bygger på Cerenkovstrålning, vilket är det optiska ljuset
som avges då elektriskt laddade partiklar färdas med hög hastighet genom vissa
medium. Vanligtvis används radioaktiva preparat som vid sönderfall avger lad-
dade partiklar med tillräckligt hög hastighet för att producera Cerenkovstrålnin-
gen. Många av de preparat som används vid PET undersökningar uppfyller dessa
specifikationer. Detta har snabbat på utvecklingen av metoden eftersom att det
redan från början fanns godkända preparat till hands. PET är också den metod
som Cerenkov avbildning jämförts mest med och flertalet studier har visat god
överenstämmelse mellan dem vid ytliga mätningar.
Potentiella tillämpningar av Cerenkov avbildning är också främst som substitut
till PET vid ytliga undersökningar. För kliniska syften har bland annat möjligheter
för sköldkörtelundersökningar och vävnadsklassifikation under kirurgiska ingrepp
diskuterats. PET undersökningar kräver att det radioaktiva preparatet som används
avger positroner vid sönderfall, detta krav finns inte vid Cerenkov avbildning, där
även preprat som avger elektroner kan användas. För rena avbildningssyften är
detta av litet intresse då preparatet som används bara ska ge kontrast och dess ex-
akta karaktär inte är av större intresse. Vid strålbehandlingar, då en patient ges
ett radioaktivt preparat för behandling, är preparatets karaktär å andra av största
intresse, eftersom att det avgör vilken effekt behandlingen får. Här skulle alltså
Cerenkov avbildning kunna användas för att monitorera och evaluera strålbehan-
dling där preparat som avger elektroner används. Vilket inte alltid är görbart med
SPECT eller PET.
I den här rapporten presenteras en Cerenkov metod för molekylär avbildning. Den
underliggande teorin för Cerenkov fenomenet och transport av ljus genom vävnad
behandlas. Utifrån denna teori är en modell för den uppmätta strålningen från ett
radioaktiva preparat presenterad. Baserat på denna modell är en avbildningalgo-
ritm uppbyggd som utifrån mätningar av Cerenkovstrålning försöker återskapa det
radioaktiva preparatets utbredning i objektet. Båda modellerna har testats med da-
torsimulationer men också experimentellt genom mätningar på vävnadsliknande
plastfantomer.
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1 INTRODUCTION
1.1 Molecular imaging
Molecular imaging is the common name for non-invasive techniques which aims
to visualize biochemical interactions and events at a molecular or cellular level.
In clinics it is used for both diagnostic and therapeutic purposes and in preclinical
studies it is an invaluable tool for researchers. Although a handful of modalities
are commercially available there is much interest in new methods and a large
amount of research is put into it.
Commonly molecular imaging is performed by introducing a marker, which is
traceable in some sense, into the subject of interest. Depending on the application
the marker may be administered in different ways. If a specific area or process is
of interest the marker can be attached to a specific molecule, known as a tracer,
which accumulates in the desired region or is involved in the particular process.
But the marker may also be injected freely into the subject. How the marker is
detected differs between techniques and in some cases external excitation of the
marker is required.
In this thesis a relatively new, experimental molecular imaging modality known
as Cerenkov luminescence imaging is investigated. A quantitative model is devel-
oped and tested to asses its potential for molecular imaging.
1.1.1 Clinical modalities
The most common clinical molecular imaging techniques today are single photon
emission computed tomography (SPECT), positron emission tomography (PET),
magnetic resonance imaging (MRI) and ultrasound imaging. Even though they
are all commercially available and commonly used in clinics, there is still a lot
work involving them in the preclinics, both for further development of them and
as imaging tools in other studies.
SPECT and PET have many similarities, both uses radioactive isotopes as mark-
ers, γ-emitters for SPECT and positron emitters for PET and the detection of the
marker is in both cases performed with a gamma camera. In SPECT the emitted γ-
photons from the radioactive decay is measured. PET on the other hand relies on
the detection of γ-photon pairs produced from annihilations of emitted positrons
and electrons in the subject. By changing the location of the camera a set of im-
ages is produced from which the spatial distribution of the marker is reconstructed.
Due to the use of γ-rays for detection these methods have good imaging capabil-
ities regardless of depth. Both methods have a high sensitivity, meaning that it is
1
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possible to detect small amounts of the marker. Major limitations to SPECT and
PET is bulky and expensive equipment, the procedure also takes quite some time
and only one subject can be imaged at a time [1]. SPECT and particularly PET
share similarities with CLI, both in methodology and application. For this reason
it is interesting to use them for comparison and as a benchmark.
MRI is a very versatile imaging technique where both anatomical and molecular
information can be reconstructed. MRI exploits atomic nuclei with a non-zero
magnetic moment as markers. Under the influence of an external magnetic field
these nuclei align either parallel or anti-parallel to the field. These two popula-
tions differ by a small fraction and this is used for detection. The difference in
population depends on the external field strength but is still very small even in the
1 Tesla range, which is common in clinical machines. This causes MRI to have
rather poor sensitivity, compared to SPECT and PET the marker concentration
must be several orders of magnitude higher to be detectable [1]. Also it does not
relate closely to CLI and will therefore not be discussed any further.
Ultrasound imaging is a well established imaging modality but its applicability for
molecular imaging have not been investigated until recent years. High frequency
sound waves are used to probe the subject and shifts in the properties (phase,
frequency, amplitude) of the reflected waves are used to reconstruct the probed
volume. Different markers exist and is generally divided into microbubble agents
and non-microbubble agents. The microbubbles are micrometre sized gas bubbles
surrounded by a shell, and are designed to give a clear echo of the sound wave
yielding a high sensitivity. The non-microbubbles are typically smaller, 10-1000
nanometre, and either solid or liquid. The smaller size gives them the ability to
reach locations microbubbles can not. They will however reflect a weaker echo
and thus results in a lower sensitivity [2]. Ultrasound imaging is relatively cheap
and the acquisition time is very short, several images can be produced per second,
making real-time imaging of the subject possible. The use of sound does however
limit the depth which is possible to probe.
1.1.2 Optical imaging
There is an extensive number of preclinical molecular imaging methods, a sub-
group of these which has fetched much interest in recent years is the optical
imaging techniques. The common part of these are the use of light in the ul-
traviolet, visible and near infra-red (UV-VIS-NIR) range. Even in this subgroup
the amount of methods is far to great to cover here and only a small selection
will be mentioned. Optical techniques typically has a higher throughput, which
basically indicates a higher sensitivity, than SPECT/PET and the instrumentation
required is often cheaper. The major limitation for optical imaging is the strong
2
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attenuation and scattering of light in the optical range. Where γ-photons usually
can pierce straight through a human body, light in the optical light will have its
original direction completely distorted after a few millimetres and its intensity
reduced below the detection threshold after a few centimetres. These effects are
strongly dependant on the type of tissue the light propagates through and also the
wavelength of the light. As the optical light has very limited range in tissue it can
often only be measured at certain parts of the subject. Compared to SPECT/PET
where measurements are available at all parts of the subject the amount of data
will generally be more limited.
Fluorescence imaging is a very popular optical imaging technique which uses
fluorophores as markers. The fluorophore is introduced into the subject, possibly
attached to a targeting agent, and then excited by some internal or external light
source. The emitted fluorescent light is measured and from this measurement the
distribution of the fluorophore is calculated. This method is rather versatile as
different fluorophores have different absorption and emission characteristics.
Bioluminescence imaging exploits the bioluminescence phenomena, where cer-
tain genes expresses substances which through chemical processes emits light.
This occurs naturally in some species, fireflies being one of the most famous,
but the genes can also be implanted into other specimen. Usually the genes are
implanted in such a way that they are expressed under some circumstance of in-
terest. Imaging is performed by measuring the luminescence and calculation a
three-dimensional representation of the bioluminescence source-distribution.
1.1.3 Cerenkov luminescence imaging
The term Cerenkov luminescence imaging (CLI) was coined by Robertson et al.
in 2009 when they studied the Cerenkov emission from the PET probe 18F-FDG
in well plates and a xenograft tumour in a mouse [3]. This method is based on the
radiation produced from charged particles travelling at high velocities through a
medium, known as Cerenkov radiation. The charged particles are produced from
the decay of some radioactive isotope and from the measurement the distribution
of the isotope is imaged. In principle an external source of charged particles could
be used to induce the Cerenkov radiation as well, but for the purpose of CLI this is
not of interest as very little molecular information would be recovered. In practice
it is mainly β-emitting isotopes that are useful for CLI as heavier particles require
far to much energy to reach the velocities needed to produce Cerenkov radiation.
Conveniently, many of the β`-emitters used for PET has proven to be useful for
CLI. The main difference between PET and CLI is thus the origin of the measured
radiation, positron-electron annihilation for PET and Cerenkov radiation emitted
by the β-particle as it travels through the subject for CLI. Due to this difference
3
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the reconstruction algorithms and detection equipment also differ. The Cerenkov
radiation is usually measured with a CCD, which in general is much smaller and
cheaper than the gamma cameras required for PET. In CLI electron emitters may
also be used as markers, giving it a larger range of available markers compared to
PET.
CLI is still a fairly experimental method and is predominantly used in small animal
or in vitro studies. For in vivo CLI the radioactive marker is usually intravenously
injected, often attached to a tracer designed to accumulate in a specific part of
the subject, like a tumour. As most other optical imaging techniques CLI is very
depth limited, perhaps even more so than some other methods due to the Cerenkov
radiation being rather weak by nature.
1.2 Applications of CLI
Due to the very limited depth at which CLI can be used, its potential clinical
applications are very limited. Instead most of its applications is in a pre-clinical
environment.
1.2.1 CLI as an alternative to SPECT/PET
CLI and SPECT/PET are basically different methods designed for the same pur-
pose, to image radioactive decay. Many of the proposed applications of CLI are
also, in some sense, as replacement for SPECT/PET. The performance of SPEC-
T/PET also provides a natural frame of reference for assessment of CLI.
A common argument for CLI is its potentially higher throughput compared to
SPECT/PET, which would imply a higher rate of data acquisition, implying that
a shorter acquisition time would be required. In SPECT each γ-decay produces
one photon and in PET each β`-emission produces a photon pair, but due to the
design of PET it will only be considered as a single detection event. Both SPECT
and PET thus has an upper limit of one detection per decay, and in practice lower
since not all photons are captured. The number of Cerenkov photons produced per
β-decay depends on the initial energy of the β-particle and also on the medium
in which the decay occurs. The amount of detected radiation will also strongly
depend on the source-detector distance. The Cerenkov radiation is emitted in
a continuous spectrum, which is quite different from SPECT/PET where the γ-
photons has a fixed energy. The detection for CLI will thus further depend on
the camera’s ability to detect light at different wavelengths. Ross presented a
table of the Cerenkov radiation produced by electrons in water, which in general
yields less Cerenkov photons than in tissue, in the 250-600 nm range [4]. In
4
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figure 1.1 these values are displayed as a function of the electron energy. Clearly
Figure 1.1: Calculated Cerenkov photons emitted from an electron travelling
through water in the 250-600 nm spectral band.
the amount of Cerenkov radiation grows quickly with the electron energy. For
electrons with initial energy of around 0.5 MeV only a few photons are emitted,
while hundreds are emitted if the energy is increased to 1.5 MeV. These energies
are within reasonable bounds for medical use, there are several PET probes which
produces β-particles with energies up to a few MeV. For high energy β-emitters
it is thus reasonable to expect several detections per decay, and thus a higher
throughput. For low energy emitters this is however more questionable.
It has been argued that CLI potentially could give a higher spatial resolution than
PET. This is due to the fact that the radiation measured in PET does not orig-
inate from the marker itself, but from the annihilation of positrons emitted by
the marker. The annihilations occur when the emitted positrons interacts with
electrons in the subject, which occurs at a random distance from the decay. The
Cerenkov radiation on the other hand is continuously emitted by the particle, fur-
thermore the radiation is stronger closer to the decay. If the reconstruction could
be performed to perfectly recover the origin of the radiation, CLI could thus be
expected to outperform PET. However, perfect reconstructions is not feasible and
it is questionable weather this effect comes into play or not.
5
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The most important advantage of CLI would still probably be the simpler equip-
ment required. SPECT and PET are rather expensive methods and CLI could
possibly increase the availability of molecular imaging to researchers.
Several studies has assessed the performance of CLI in different settings. Both
in vitro and in vivo experiments with different radioisotopes as markers has been
conducted. Despite the different settings the conclusion has been similar, it is
indeed possible to detect the Cerenkov radiation and the reconstruction of the
radionuclei correlate well with SPECT/PET [5–14]. The spatial resolution found
in these studies has been comparable to the resolution of SPECT/PET.
1.2.2 Other proposed applications of CLI
A possible clinical applications of CLI is monitoring of the thyroid gland. This
could be possible due to the thyroid being located close to the skin. Initial studies
in mice has shown promising results CLI [7,15]. Cerenkov imaging of the thyroid
in a human after treatment with 131I, possibly the first Cerenkov image of a human,
has also been performed [16], proving its clinical potential.
Due to the much smaller detection device and shorter acquisition time for CLI
compared to PET it has been proposed as an intraoperative guidance tool. With
current techniques, often SPECT or PET, surgeons have to relay on pre-operative
images. CLI (and other OI techniques) on the other hand could potentially be used
during surgery to provide updated images during the procedure. Studies show that,
although more work needs to be done, it is feasible [17, 18].
CLI has great potential for assessment of radiation therapy. For imaging purposes
the characteristics of the marker is normally not that important, as long as it pro-
vides good contrast. For radiation therapy however the characteristics of the radi-
ation source is crucial for the outcome of the treatment. Neither SPECT nor PET
can directly image electron emitters and therefore the assessment of their poten-
tial for therapy is somewhat more complicated then gamma or positron emitters.
The possibility to image electron emitters with CLI would offer an easier way of
assessing the potential for such isotopes [11, 12].
The possibility to image α-emitters with CLI has also been discussed. The α-
particles themselves would not be energetic enough to produce Cerenkov radia-
tion, over 1 GeV is required and the energy of emitted α-particles will typically be
below 10 MeV. However it is common that the nucleus undergoes several rapid de-
cays after the initial α-decay. These subsequent decays may be of different type,
and often some of them are β or γ-decays. These β-particles may be energetic
enough to be useful for CLI, it may also be possible for the γ-rays to produce high
energy electrons through Compton scattering. While it is possible for Cerenkov
6
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radiation to be produced in this way, the time delay between decays and the num-
ber of different isotopes makes the reconstruction problem much harder [19].
Another interesting possibility is the use of Cerenkov radiation as a source for
excitation light. A few studies has investigated Cerenkov radiation as excitation
for fluorescent imaging [20–22]. It has also been proposed as excitation for pho-
tosensitizers during photo dynamic therapy [23]. The advantage with Cerenkov
radiation over conventional light sources would be the production of light within
the subject, and it should thus not be as heavily attenuated. While these applica-
tions does not directly involve CLI it could be of interest to monitor the excitation
field, as it heavily affects the results, which could be done using CLI. In these
cases the Cerenkov radiation is not used for the actual imaging and an external
β-source is thus a feasible alternative to radioactive isotopes [24, 25].
1.3 Purpose
CLI has emerged as a promising new modality for molecular imaging of radioac-
tive decay in vivo. In this work the underlying theory for the Cerenkov phenomena
and and the transport of the produced radiation through tissue is presented. This
theory is used to formulate a mathematical model which quantifies the amount
of Cerenkov radiation produced in a subject. From this model a reconstruction
algorithm is presented, which estimates the distribution of the radioactive marker.
The primary purpose of this work is thus to present a theoretical CLI framework.
The results presented will mainly be used as validation for this particular frame-
work rather than assessing CLI as a method.
1.4 Aims
In this thesis a forward model for the propagation of Cerenkov radiation will be
constructed. This model should for a given subject with known properties as well
as a known distribution of a radionuclide calculate the stationary distribution of
Cerenkov radiation within the subject as well as the radiation leaving through its
boundaries. Key components to this model is the calculation of emitted radiation
from a radionuclide and the propagation of it through the subject.
Based on the forward model an inverse model to reconstruct the activity distri-
bution from boundary measurements of the Cerenkov radiation will be presented.
Primarily good reconstruction of the location and shape of the radionuclide distri-
bution is of interest.
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1.5 Assumptions
Optical imaging is a notoriously hard subject and CLI is no exception, for this
reason several approximations and simplifying assumptions are made.
• The Cerenkov radiation produced from a β-particle depends on its energy,
which in turn is stochastic. As a deterministic approach is taken expected
values are used wherever necessary.
• Scattering of β-particles is neglected.
• The Cerenkov radiation is assumed to be isotropically emitted.
• The optical characteristics of the subject is assumed to be accurately mod-
elled by its refractive index, absorption and scattering coefficients, anisotropy
factor and scattering phase function. Further more the scattering phase func-
tion is assumed to be well approximated by the Henyey-Greenstein phase
function.
• The equation governing the transport of light through the subject is assumed
to be well estimated by a low-order simplified spherical harmonic approxi-
mation.
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2.1 Cerenkov radiation
Cerenkov radiation is the light which can be observed when highly energetic
charged particles travel through certain materials. A common example of Cerenkov
radiation is the blue light surrounding a nuclear reactor submerged in water. It
was explained by Pavel Alekseyevich Cerenkov in the 1930s, for which he was
awarded the 1958 Nobel price in physics.
2.1.1 Emission
In a dielectric medium the electric field surrounding a charge will polarize nearby
atoms or molecules. If the charge is moving the atoms or molecules will return
to their ground states as the charge passes them by. During the transition of the
atoms or molecules to their ground states photons are emitted. However, if the
charge is moving at a low velocity the photons emitted will interfere destructively
and no radiation is observed at a distance. If the charge on the other hand travels at
a high velocity there will be constructive interference at a certain angle relative to
the direction of the charge. This results in a light cone centred around the charge
and it is this light which is referred to as Cerenkov radiation [26]. The angle θ at
which photons are emitted is given by Cerenkov’s relation
cos θ “ 1
βn
. (2.1)
Here β is the speed of the charge divided by the speed of light in vacuum and n
is the refractive index of the medium. The threshold velocity of the charge for
Cerenkov emission to occur is the phase velocity of light in the medium, which
can be stated as
βn ą 1.
Cerenkov radiation can consequently only occur in dielectric media with a refrac-
tive index greater than unity. The requirement for the charge to be superluminal
can also be stated as a requirement for the charge to travel faster than its own
electromagnetic bow wave.
2.1.2 Frank-Tamm theory
The amount Cerenkov radiation emitted per unit path length travelled by a particle
carrying a charge q is given by the Frank-Tamm formula [26]
dE
dx
“ q
2
c2
ż
βną1
ˆ
1´ 1
β2n2
˙
ω dω. (2.2)
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The integral in 2.2 might seem divergent as ω goes to infinity but in practice the
refractive index will go to (or even below) unity for high frequencies, making the
Cerenkov condition impossible to satisfy. In most cases the emitted energy in
a certain spectral band is of interest, rather than the total output. This is easily
achieved by limiting the integral in 2.2 to the interval rω1, ω2s of interest, given
that the Cerenkov condition holds in the interval. An extension to the Frank-
Tamm theory was developed by Budini, which characterizes the medium by a
complex dielectric function rather than the refractive index. This theory results in
convergent expression for the Cerenkov emission [27]. However in the spectral
range of interest for CLI the original expression 2.2 has been found to describe
the Cerenkov emission well [28, 29].
In optical imaging applications it is commonly preferred to work with wavelength
rather than angular frequency. The corresponding formulation is found by using
the relation
ω “ 2pic
λ
.
This yields the wavelength formulation of the Frank-Tamm formula
dE
dx
“ 4pi2q2
λ2ż
λ1
ˆ
1´ 1
β2n2
˙
1
λ3
dλ, (2.3)
where λ1 corresponds to ω2 and λ2 to ω1, thus λ1 ă λ2 (note the change of
order in integration limits). The particles velocity does not depend on λ and if the
refractive index can be assumed to be constant in the interval rλ1, λ2s 2.3 can be
further simplified as
dE
dx
“ 4pi2q2
ˆ
1´ 1
β2n2
˙ λ2ż
λ1
1
λ3
dλ “ 2pi2q2
ˆ
1´ 1
β2n2
˙ˆ
1
λ21
´ 1
λ22
˙
. (2.4)
From 2.4 it can be seen that the spectrum of the Cerenkov radiation is proportional
to λ´3, that is
dE
dλ
9 1
λ3
. (2.5)
In this formulation of the Frank-Tamm theory units are chosen so that the permit-
tivity factor 4piε0 “ 1 and dimensionless. From the definition of the fine structure
constant α this implies that other units should be chosen so that
e2 “ α~c, (2.6)
where e is the fundamental electric charge, ~ the reduced Plank’s constant and c
the speed of light in vacuum.
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2.2 β-decay
Radioactive decay is the natural process through which unstable atomic nuclei is
converted to more stable ones. During β-decay a proton in a nucleus is converted
to a neutron, or vice versa, changing its atomic number by one while leaving its
mass number unchanged. To maintain the conservation of electric charge during
the conversion an electron or positron is emitted. The two modes of decay are
often distinguished by the abbreviations β´-decay, which indicates the emission
of an electron, and β`-decay which indicates that a positron is emitted. Along
with the β-particle a neutrino or anti-neutrino is emitted. The general form of an
element A transitioning to another element B through β-decay is thus
N
ZA Ñ NZ˘1B` β ` ν. (2.7)
2.2.1 Energy of emitted β-particles
The difference between the energy of the parent and the daughter nucleus deter-
mines the total energy of the β-particle and the neutrino. Apart from the fact that
each particle must carry at least its rest mass in energy, there is no restriction as to
how the energy is distributed. The kinetic energy of emitted β-particles will thus
form a continuous probability distribution between 0 and some maximum value
(and likewise for the neutrino). The probability distribution as well as the maxi-
mum kinetic energy varies between different radioactive isotopes and is governed
by Fermi theory [30]. In this work energy distributions from the RADAR decay
database has been used [31].
2.2.2 β-range and stopping power
When β-particles travel through a medium they gradually lose their energy through
different interaction. Two types of interactions occur, inelastic collisions which
includes ionization or excitation of atoms and molecules. The other type is elastic
interactions which is Bremsstrahlung [32,33]. These interactions occur at discrete
times and the loss of energy will thus be in discrete steps.
A common strategy to model these rather complicated interactions is to assume
that the particle looses its energy continuously at some average rate with respect to
the available interactions. This is known as the continuous slowing down approx-
imation (CSDA). The average rate of energy loss per unit path length is referred
to as the stopping power SpEq. The stopping power depends on the energy of
the particle, as the probability of different interactions changes with the energy,
and also on the medium. The stopping power is usually decomposed as a sum of
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the stopping power due to collisions (inelastic interactions) and radiation (elastic
interactions). The stopping power used in this work has been interpolated from
ESTAR Stopping Power and Range Tables, provided by the National Institute of
Standards and Technology [34].
With this model the energy loss is governed by the equation
dE
dx
“ ´SpEq, Ep0q “ E0, (2.8)
where Epxq is the kinetic energy of the particle and E0 its initial kinetic energy.
In addition to losing energy the β-particles may have their direction of travel
changed by the above mentioned interactions. This scattering has however been
neglected due to the complexity of it.
In the Frank-Tamm theory it was the relative speed of the particle rather than
its kinetic energy which was used to calculate the Cerenkov emission. From the
relativistic expression of energy a conversion formula can be found as
βpxq “
«
1´
ˆ
E0
Epxq ` E0
˙2ff 12
, (2.9)
where E0 its rest mass of the particle (0.511 MeV for β-particles).
There is a small discrepancy between the stopping power for electrons and positrons
[35,36]. It is however small in the energy region of interest and will therefore not
be considered and the ESTAR data for electrons will be used for positrons as well.
2.3 Cerenkov radiation from β-decay
To perform CLI the amount of Cerenkov radiation produced by a radioactive sam-
ple has to be assessed. This can be achieved by combining the Frank-Tamm theory
and the CSDA model for emitted β-particles. Due to the random initial energy of
the β-particles the emitted Cerenkov radiation will also be random. In any practi-
cal situation the sample will however contain a large number or radioactive nuclei
and it is fair to assume that the emitted radiation will be close to its expected value.
2.3.1 Average Cerenkov radiation from a decay
From a known initial energy of a β-particle its energy as a function of path trav-
elled is found through 2.8. By applying 2.9 the relative speed β as a function
of path is obtained and by plugging it into 2.4 the rate of Cerenkov emission is
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found. In a certain spectral band with known material properties the Cerenkov
emission thus only depends on the initial β-energy. By calculating the expected
Cerenkov emission with respect to a certain isotopes energy distribution, the aver-
age Cerenkov emission from a decay of that isotope is found. The expected value
is given by
E rEprqs “ 2pi2e2dr
ˆ
1
λ21
´ 1
λ22
˙ 8ż
ECer
ˆ
1´ 1
βprq2n2
˙
fpE0q dE0, (2.10)
where r is the distance along the trajectory from the decay, fpE0q the energy
distribution and ECer the threshold energy for Cerenkov emission. Frequently it
will be of interest to calculate the expected Cerenkov emission from a particle at
a certain part of its trajectory. This can be calculated by integrating 2.10 over the
region of interest,
ErEpr1, r2qs “
r2ż
r1
E rEprqs dr. (2.11)
From 2.10 the expected Cerenkov emission along the trajectory of a β-particle is
given. This trajectory is however unknown as the direction at which the β-particle
is emitted at is random. Rather than 2.10 the expected Cerenkov emission at an
arbitrary point r is the quantity of interest. Assuming the direction of the emitted
β-particles is uniformly distributed and that the decay occurs in the origin this is
expected value is
E rEprqs “
ż
4pi
E rEp|r|qs δ
ˆ
1´ s ¨ r|r|
˙
1
4pi
ds “ 1
4pi
E rEp|r|qs . (2.12)
Here δ is a translated Dirac pulse which indicates that only trajectories through
r will contribute to the emitted energy. The factor
1
4pi
is the uniform probability
distribution for the β-particle directions.
In the case r “ 0, 2.12 breaks down. In the continuous case, where the subject
consists of a continuum of points, this is not a problem. It is however convenient
to have an expression for all points and as 2.10 is defined for r “ 0, 2.12 is simply
extended as
E rEprqs “ 1
4pi
E rEp|r|qs @ r. (2.13)
The expected emission at an arbitrary point is thus only dependent on the distance
from the decay, which is expected since isotropic decay is assumed. It can also be
seen that by integrating 2.12 over all directions 2.10 is recovered, as expected.
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Finally the expected emission is normalized with a volume element dV as it is
often preferable to express a source in units of energy per volume. The expected
Cerenkov source from a single decay is then
QCerprq “ QCerp|r|q “ 1
4pi
E rE p|r|qs
dV
. (2.14)
2.3.2 Cerenkov radiation from an activity distribution
The rate at which a radioactive sample decays at is measured by its activity. Ac-
tivity is commonly given in units of Becquerel (Bq) which is decays per second in
the sample. The activity measures the total decays within the sample and does not
hold any spatial information about the distribution of the radioactive compound
within the sample. In order to resolve the radioactive inhomogeneities in the sam-
ple the activity distribution (or density), which is given as activity per volume, has
to be considered.
The Cerenkov source scales linearly with the number of decays, and therefore also
linearly with activity. The total source from the activity distribution A will thus
be the sum of the decay in each point weighted by QCer
Qprq “
ż
Apr1qQCerp|r ´ r1|q dr1, (2.15)
which can also be formulated as a convolution in three dimensions. This is the
average total emitted power per volume and is thus the expected Cerenkov source
from A.
The source term 2.15 is isotropic, which might seem odd due to the specific angle
Cerenkov radiation is emitted in. However in an activity distribution Qprq will
receive contributions from decays at several locations. On average it might thus
be reasonable to assume that the contributions will be given from all directions
equally, which will result in isotropic Cerenkov emission. Furthermore biologi-
cal tissue is strongly scattering, implying that any directional dependence of the
source will be suppressed.
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2.4 Light transport in tissue
For a photon in the UV-IR range travelling through matter, there are two kinds
of interaction to be considered. Absorption of the photon and scattering, which
causes the photon to change its direction with all of its energy preserved.
2.4.1 Absorption
Certain molecules, called chromophores, have the ability to absorb light. This
ability to absorb is usually wavelength dependent and can be characterized by a
absorption coefficient µapλq. The absorption coefficient determines the rate at
which light travelling through a medium loses its intensity, governed by the Beer-
Lambert law
Ipxq “ I0e´µapλqx. (2.16)
In a composite material the absorption coefficient will be a weighted sum of each
of the constituent chromophores absorption coefficients
µa “
ÿ
i
µaifi.
The weights fi are the volume fractions of the chromophores in units of volume
chromophore per volume medium, and is thus dimensionless.
In biological tissue the most influential chromophores are oxygenated haemoglobin
(HbO2), deoxygenated haemoglobin (Hb), water and lipids. Instead of specifying
the volume fraction of both kinds of haemoglobin it is common to specify the total
volume fraction of blood B and use the blood oxygen saturation S to distinguish
them. This gives an absorption coefficient for the tissue
µa “ µaHbO2BS ` µaHbBp1´ Sq ` µaH2OW ` µalipidL, (2.17)
where W and L are the water and lipid volume fractions respectively.
Values of the absorption coefficients for each chromophore has been taken from
[37]. While those values are rather definite the volume fractions and saturation
varies a lot between tissue types and also between individuals. With some inspi-
ration from [38] values for a soft tissue was chosen as
B “ 0.04 S “ 0.7 W “ 0.7 L “ 0.1.
The corresponding total absorption coefficient for this tissue is shown in figure
2.1.
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2.4.2 Scattering
Scattering of light in tissue occurs mainly due to interactions with large particles
(large compared to the wavelength of the light), known as Mie scattering and by
refractive index mismatches at interfaces. Analogously to the absorption coeffi-
cient the scattering coefficient µs is defined as the average number of scattering
events per unit length.
It is however not enough to characterize the frequency of scattering events, the
change in direction must also be described. This is done with the scattering phase
function pps1, sq, which describes the probability of a photon scattering from di-
rection s1 to s.
The true scattering phase function of a material is usually unknown, but it is often
assumed that it only depends on the angle between s1 and s. In these cases it
is common to assume that scattering phase function is well-approximated by the
Henyey-Greenstein phase function [39]
pHGps1, sq “ 1
4pi
1´ g2
p1` g2 ´ 2gps1 ¨ sqq 32 . (2.18)
Which depends on the parameter g known as the anisotropy factor. The anisotropy
factor is the mean of the cosine over the true scattering phase function
g “
ż
4pi
ż
4pi
s ¨ s1pps, s1q ds ds1, (2.19)
and is thus a number in the range [-1,1]. Values close to 1 indicates that the ma-
terial is forward scattering, values close to 0 that the material is close to isotropic
and values close to -1 that the material is backwards scattering.
Instead of µs it is common to use the reduced scattering coefficient µ1s “ µsp1´gq.
Employing the theory of Mie scattering µ1s can be modelled as
µ1spλq “ a
ˆ
λ
λ0
˙´b
, (2.20)
where λ0 is some reference wavelength of choice. With this construction a should
be chosen as µ1spλ0q and b, sometimes referred to as the scattering power, describes
the size distribution of the scattering particles.
Values for a and b in a soft tissue has, with inspiration from [38], been chosen as
a “ 1.5 mm´1 b “ 1.2
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for λ0 “ 500 nm. The reduced scattering coefficient calculated with this model
is shown in figure 2.1. Biological tissue is typically strongly forward scattering
and the anisotropy factor for the soft tissue was chosen as g “ 0.95. In general g
might be wavelength dependant, but has for simplicity been considered constant
in this case.
Figure 2.1: Optical properties used to model a soft tissue. Note that it is the
reduced scattering coefficient µ1s which is shown.
2.4.3 Radiative transport
The transport of photons in a turbid media, such as tissue, is described by the
radiative transport equation (RTE). The time resolved RTE is a balance equation
which governs the radiance at a point r in direction s with wavelength λ at a
given time t, Lpr, s, λ, tq. The radiance is a measure of the light intensity in units
of power per area per solid angle.
The equation is deduced by considering a small volume V with boundary BV . The
total change in radiance in V over a short time interval is thenż
V
BL
Bt dV,
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which will be equal to the difference between radiance gained and radiance lost
in direction s inside of V . Radiance is gained from sources Q within V and by
scattering from directions sˆ1 onto sˆż
V
QdVlooomooon
Sources
`
ż
V
c1µs
ż
4pi
pps1, sqLds1 dVloooooooooooooooomoooooooooooooooon
Scattering onto s
.
Here c1 is the speed of light in the medium and pps1, sq is the scattering phase
function. Radiance is lost through absorption and scattering
´
ż
V
c1µaLdVloooooomoooooon
Absorption
´
ż
V
c1µsLdVlooooomooooon
Scattering
.
Radiance may also be gained or lost by crossing the boundary BV . For an out-
wards pointing normal vector n of unit length this term is
´
ż
BV
c1s ¨ nLdSlooooooomooooooon
Crossing of BV
.
By adding up these terms and dropping the volume integral, the time resolved
RTE is found as
BL
Bt “ Q` c
1µs
ż
4pi
pps1, sqLds1 ´ c1pµa ` µsqL´ c1s ¨∇L. (2.21)
For CLI purposes the radiance is often assumed to vary slowly compared to the
time required for measurements. In this case it is thus preferable to work with the
stationary RTE, given by
0 “ Q` c1µs
ż
4pi
pps1, sqLds1 ´ c1pµa ` µsqL´ c1s ¨∇L. (2.22)
Often the directional dependence of the radiance is of little interest and instead
the fluence rate Φ is used, which is defined as
Φ “
ż
4pi
Lds. (2.23)
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2.4.4 Boundaries
The geometry considered in image applications is typically a subject Γ with a
boundary BΓ surrounded by an infinite media. The surrounding media is often
air and is then assumed to behave like vacuum, i.e no scattering or absorption
and with unit refractive index. All sources are assumed to be contained within Γ,
this assumption is not always true, e.g in fluorescence imaging the excitation light
often originates from external sources. In the case of CLI it is however valid as
Cerenkov radiation can only be produced inside the subject where the refractive
index is greater than unity. The light propagation in the interior of Γ is given by
2.22, but the behaviour on the boundary BΓ must still be described.
Photons reaching the boundary BΓ, travelling in direction s, will either leave Γ or
be reflected back into Γ. The probability of reflection, R, is given by Fresnel’s
equations
Rpcosϕq “
$’&’%
1
2
«ˆ
nΓ cosϕ
1 ´ n0 cosϕ
nΓ cosϕ1 ` n0 cosϕ
˙2
`
ˆ
nΓ cosϕ´ n0 cosϕ1
nΓ cosϕ` n0 cosϕ1
˙2ff
ϕ ă ϕc,
1 ϕ ě ϕc.
(2.24)
Here ϕ is the incident angle, satisfying cosϕ “ s ¨ n where n is an outwards
directed unit normal vector. The transmission angle ϕ1 is given by Snell’s law
n0 sinϕ
1 “ nΓ sinϕ, (2.25)
and ϕc is the critical angle for total internal reflection satisfying nΓ sinϕc “ n0.
The new direction s1 of the reflected photons will satisfy
s “ s1 ´ 2ps1 ¨ nqn. (2.26)
The other possible source of boundary photons directed into Γ is a boundary
source, adding these together the partially reflecting boundary condition is found
as
Lpr, s1q “ Qpr, s1q `Rps ¨ nqLpr, sq, r P BΓ, s1 ¨ n ă 0, (2.27)
where s is given by 2.26.
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2.4.5 Detection
Photons crossing the boundary BΓ can be detected with an external light sensi-
tive device. While interior detection is possible it is not common in the field of
molecular imaging and will not be considered in this work. The scored quantity of
these measurements are the exiting partial currents J` of photons at the boundary,
which is given by
J`prq “
ż
s¨ną0
r1´Rps ¨ nqsLpr, sqs ¨ n ds. (2.28)
The actual measurement also depends on the device used as all photons reaching
the detector wont be registered. This is described by the camera’s quantum effi-
ciency (QE) is the ratio of detected photons to total photons entering the aperture.
The quantum efficiency is generally wavelength dependent and varies between
devices.
The measurements M will be proportional to
Mpr, λq 9 QEpλq J`pr, λq (2.29)
if the device is spectrally resolved, otherwise
Mprq 9
ż
QEą0
QEpλq J`pr, λq dλ. (2.30)
Most detection devices operate by converting detected light to electrical currents.
The measured values will thus not be in any ordinary units of light intensity. The
relationship between incoming light and pixel values should however be linear.
The measurements can thus be converted back to any intensity unit of choice by
multiplication with a calibrating factor. This calibration factor is commonly found
experimentally by measuring some well defined amount of light.
2.4.6 The simplified spherical harmonics approximation
Solutions to the RTE are notoriously hard to calculate, especially in more complex
geometries. For this reason numerous methods to approximate it has been devel-
oped. The most widely used is the diffusion approximation, which belongs to a
family of methods known as the spherical harmonics approximations, often abbre-
viated PN . These are found by expanding L into a series of spherical harmonics,
which results in a set of coupled partial differential equations. The popularity of
the diffusion approximation is much due to it reducing down to a single, rather
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simple equation. The simplicity of it comes at the cost of some rather strong as-
sumption which limits its validity regions where the light is diffuse. This limits its
use to media where µa ! µ1s and to regions sufficiently far away from anisotropic
sources. To overcome these limitations higher order approximations can be used,
the complexity of the PN methods does however increase rapidly with the order.
As an alternative to the complicated high order PN equations the simplified spher-
ical harmonics, denoted SPN , was developed. The first order SP1 and P1 meth-
ods are both equivalent to the diffusion approximation. For higher orders the
SPN methods are however, as the name suggests, simpler than the PN methods.
The SPN approximation in three dimensions was originally deduced from the PN
equations in one dimension by simply interchanging the spatial derivative with the
gradient
B
Bx Ñ ∇.
For odd orders N this yields a system of k “ N ` 1
2
coupled partial differential
equations
´∇ ¨D∇ϕ “ νQ`Λϕ, (2.31)
where
D “
¨˚
˝ D1 0. . .
0 Dk
‹˛‚ ϕ “
»—– ϕ1...
ϕk
fiffifl ν “
»—– ν1...
νk
fiffifl Λ “
¨˚
˝ Λ1,1 . . . Λ1,k... . . . ...
Λk,1 . . . Λk,k
‹˛‚
which is a set of diffusion-like equations without any cross-terms [40]. Here ϕi
denotes the ith composite Legendre moment of the radiance andDi, νi and Λi,j are
coefficients depending on the optical parameters µa, µs and g. From the composite
Legendre moments the radiance can be recovered as the linear combination
L “ νTϕ. (2.32)
While this approach resulted in fewer and simpler equations than the PN ap-
proximation, the original deduction was theoretically weak and was therefore not
widely employed. A more rigorous theory for the method was however presented
in the 90s showing that the SPN equations produce solutions similar to the PN
method [41–43]. With this theory the SPN methods gained interest and has since
been used in a variety of applications, including CLI [44].
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2.5 Inverse problem
So far the propagation of light in a subject from a given source has been described,
which is commonly referred to as the forward problem. In optical imaging the
goal is to achieve the opposite, that is to retrieve information about the source or
subject given measurements of emitted radiation. This is usually referred to as the
inverse problem. In CLI it is the activity distribution which is of interest, but in
other applications it might be other quantities, e.g optical properties.
A common way to formulate an inverse model is to develop a forward model
Fpθ,Xq “M , (2.33)
where θ contains known parameters, X contains the unknown properties and M
are the predicted measurements. An estimate of the unknowns can then be found
by fitting measurements to this forward model. This results in an estimate Xˆ
which minimizes the difference between measurement Y and forward model
Xˆ “ min
X
ΩpXq “ min
X
}Y ´ Fpθ,Xq}. (2.34)
2.5.1 Regularization
Often the forward model is not injective, at least not to numerical precision, which
implies that there are different X which produces very similar output. This is
problematic since 2.34 does not have a unique solution these cases. This implies
that even if a solution is found, it might not be close to the actual solution. For
this reason the problem needs to be regularized, which is usually performed by
modifying 2.34 to
Xˆ “ min
X
}Y ´ Fpθ,Xq} ` λ}GpXq}. (2.35)
Here G is some function or operator which is small when X has some desirable
properties and λ the regularization parameter, determining how much impact the
regularization has on the optimization. The preferred properties of the solution is
often that it should be smooth in some sense. Commonly an iterative scheme is
employed for the optimization with a homogeneous initial guess. In each itera-
tion the error between measurements and the output from the forward model with
the current estimate of X is calculated. Based on the error and the regularization
the estimate is updated, the details of this step depends on the optimization algo-
rithm used. This is repeated until some termination criteria is fulfilled and the last
estimate is returned as a solution to the inverse problem. During the iteration it
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Figure 2.2: Flow chart of iterative inverse model.
is common to let the regularization parameter decrease, as a smaller value of λ
brings the regularized problem 2.35 closer to the original 2.34. In 2.2 the basic
outline of this type of scheme is shown.
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3.1 Forward model
The radiative transport equation 2.22 along with its boundary condition 2.27 and
the source term 2.15 constitutes the forward model for the propagation of Cerenkov
radiation. The SPN approximation to the equation is employed but the problem
is in general still not analytically solvable, thus numerical methods are required.
A finite element method is employed, which transforms the model into a linear
system over a discretization of the subject.
3.1.1 Discretization
The subject is discretized into N nodes, each specified by its spatial coordinates.
In each node the optical properties absorption, scattering, anisotropy and refrac-
tive index are specified, allowing for both homogeneous and inhomogeneous sub-
jects. In this way the geometry and optical characteristics of the subject is given.
The activity distribution is also specified in each of the nodes. Furthermore bound-
ary nodes can be flagged as detector nodes, specifying that the calculated intensity
in these nodes should be extracted as measurements.
As a FEM approach is chosen the subject must also be divided into small elements,
this is performed by a tetrahedral triangulation of the nodes. This triangulation can
be performed in numerous ways, in this case a Delaunay triangulation has been
chosen. This method guarantees that no nodes will reside in the interior of any
circumsphere to the elements, which will limit the amount of skinny tetrahedrons.
Nodes belonging to the same element will be referred to as neighbouring nodes.
The FEM discretization of 2.31 yields a system of kN ˆ kN linear equations
AkΦk “ qk, (3.1)
where once again
k “ SPN order ` 1
2
.
Here Φk is the discretization of the composite Legendre moments for the fluence
rate, qk is the source vector and Ak the stiffness matrix. As the Cerenkov source
is assumed to be isotropic the solution to 2.31 will also be isotropic, therefore the
fluence rate can be used instead of the radiance. From the composite moments the
actual fluence is recovered equivalently as radiance from the linear combination
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2.32. The source vector is given by
qk “
»—– ν1q...
νkq
fiffifl , (3.2)
where q is the discrete Cerenkov source vector, i.e the vector containing the
Cerenkov source in each node.
To calculate the Cerenkov radiation a spectral band needs to be specified. In the
implementation several spectral bands may be specified, and the the fluence rate
in each of them will be separately calculated. Optical properties must be constant
within each spectral band and the spectral bands must thus be chosen to accurately
represent eventual wavelength dependencies.
3.1.2 Implementation
In order to solve 3.1 for Φk the stiffness matrix Ak and the source qk must be
found. The stiffness matrix has been calculated using the NIRFAST software.
NIRFAST is an open source toolbox for Matlab with routines for modelling of
optical light propagation in turbid media [45, 46]. NIRFAST provides methods to
generate stiffness matrices for the SP1 ´ SP7 approximations.
A discrete version of the source in node i is, adopting earlier notation,
qi “
Nÿ
j“1
1
4pi
1
∆Vj
ż bji
aji
ErEprqs drAj∆r1j. (3.3)
Here aji and b
j
i are some distances between which the Cerenkov radiation produced
from decays in node j is considered to belong to node i. The volume elements
∆Vj and ∆r1j both describe the volume which node j represents and they will thus
cancel out. Finally Aj is the activity density in node j. The distances has been
modelled as
aji “ dji ´ ∆ri2 b
j
i “ dji ` ∆ri2 , (3.4)
where dji is the distance between node i and j and ∆ri is some distance related
to the density of nodes in the vicinity of node i. The integral in 3.3 is further
approximated by
dji´∆ri2ż
dji´∆ri2
ErEp|r|qs dr « ErEpdji qs∆ri. (3.5)
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Inserting this approximation back into 3.3 yields the discrete source
qi “
Nÿ
j“1
1
4pi
ErEpdji qsAj∆ri, (3.6)
where ErEpdji qs is calculated as a discrete version of 2.10
ErEpdji qs “ 2pi2e2dr
ˆ
1
λ21
´ 1
λ22
˙ÿ
i
ˆ
1´ 1
βprq2n2
˙
fpE0iq∆E0. (3.7)
The node distance ∆ri was chosen as the average distance between node i and its
neighbouring nodes.
As the siffness matrix often is very large an iterative method is used to solve 3.1.
In this implementation a preconditioned, biconjugate gradient stabilized method
has been employed, with an incomplete Cholesky factorization as preconditioner.
All implementation has been performed in Matlab, with the exception of a few
NIRFAST routines which are executed in C. Existing NIRFAST routines has been
used where applicable, mostly methods for mesh handling, matrix generations
and solution extraction. NIRFAST provides a rigorous framework for fluores-
cence modelling which has been used as a template for the implementation of this
Cerenkov model. The outline of the forward model is presented in algorithm 1.
3.2 Inverse model
In CLI it is the activity distribution which is of interest to reconstruct. To do so
the optimization approach 2.34 is adopted. In this case the variable vector X
thus contains the activity density in each node, which is N unknowns. All other
relevant properties are assumed to be known, and are thus all contained in θ. The
measurements Y contains M measurements at given locations on the boundary
of the subject in one or more spectral bands, M can thus be decomposed as
M “ number of detector nodes ˆ number of spectral bands. (3.8)
Measurements at the same location but in different spectral bands is thus consid-
ered to be completely separate measurements.
26
3.2. INVERSE MODEL METHODS
Algorithm 1 Forward model
1: meshÐ discretization of subject
2: ErdE
dr
s Ð 2pi2e2
´
1
λ21
´ 1
λ22
¯ř
i
´
1´ 1
β2n2
¯
fpE0iq∆E0
3: Ak Ð generate_matrixpmesh, kq
4: for i “ 1, . . . , N do
5: for j “ 1, . . . , N do
6: dji Ð distance between node i and j
7: end for
8: ∆ri Ð avarage distance between node i and its neighbours
9: qi Ð ř
j
1
4pi
ErdE
dr
pdji qsAj∆ri
10: end for
11: qk Ð rν1qT . . . νkqT sT
12: P Ð incomplete_Choleskey_factorizationpAkq
13: Φk Ð BICGSTABpAk, qk, P q
14: Φ Ð ř
i
νiΦ
k
i
15: Y Ð extract Φ at detector nodes
3.2.1 Linearity
As earlier mentioned the Cerenkov source term depends linearly on the activity.
From 2.22 it can be seen that the radiance also depends linearly on the source,
which in turn implies that the radiance depends linearly in the activity. In the
discrete case the forward model is a map from the N nodes onto the M measure-
ments
F : N ÑM.
Since F depends linearly on the activity distributionX it can be expressed as
FpXq “ JX `C, (3.9)
where J is the constant M ˆN Jacobian matrix of F and C is a constant vector.
Where obviously C “ 0 since X “ 0 implies zero Cerenkov emission and thus
zero detection. This has the rather simple interpretation that each measurement is
a weighted sum of the contributions from all nodes.
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3.2.2 Minimization
The fitting error between the measurements and an activity distribution is defined
as
δ “ Y ´ FpXq, (3.10)
and the function to minimize, ignoring regularization for the moment, is
Ω “ δTδ. (3.11)
The first order condition for the minimization of 3.11 is
dΩpXq
dX
“ ´2JTδ “ 0. (3.12)
An iterative approach is employed to find activity distributions which satisfy 3.12.
The ith fitting error is
δi “ Y ´ FpXiq “ Y ´ JXi. (3.13)
This can be further expanded to
Y ´ JXi “ Y ´ JXi´1 ´ JpXi ´Xi´1q “ δi´1 ´ J∆Xi. (3.14)
Inserting this into 3.12 yields the update equation
JTJ∆Xi “ JTδi´1, (3.15)
from which the next estimate is found asXi “Xi´1 `∆Xi.
3.2.3 Regularization
The matrix JTJ is often poorly conditioned, causing numerical solutions of 3.15
to be inaccurate. As discussed earlier there is also often multiple solutions to
it. Regularization was presented as a way of directing the optimization towards
solutions with certain properties. The regularization can also stabilize the equation
from a numerical point of view.
A common strategy is to start the iteration with a large λ, to force early estimates
to be smooth and then gradually lower it. As λ decreases the estimates should
approach a solution to 3.12 while hopefully maintaining the smoothness from the
early iterations.
One way to regularize the problem is to add a diagonal matrix λI to JTJ , which
stabilizes it since diagonally dominant matrices always are invertible. This ap-
proach results in the Levenberg-Marquardt algorithm given by the update equa-
tion “
JTJ ` λI‰∆Xi “ JTδi´1. (3.16)
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For small values of λ 3.16 behaves similarly to 3.15 and thus produces similar
updates, but might still suffer the numerical instabilities. Large values of λ will
on the other hand yield good numerical robustness but will typically result in
a slower convergence. Another interpretation is that for small λ the algorithm
behaves similarly to the Gauss-Newton algorithm and for large λ as the method of
gradient descent. This further motivates an initially large regularization parameter
which gradually decreases as the gradient descent will be preferable far from an
optimum, early iterations, while Gauss-Newton has superior performance close to
an optimum.
In terms of 2.35 this regularization is equivalent to the minimization of
Ωλ “ }Y ´ FpXq}2 ` λ}X ´Xest}2, (3.17)
where Xest is chosen as the previous estimate of X , i.e Xest “ Xi´1 for all i.
This regularization will thus penalize new estimates for deviate from the previous
ones. While this might cause a slower rate of convergence it should result in
consecutive estimates to have similar shape and smoothness. If the initial guess is
smooth it is thus likely that the resulting, final estimate will be rather smooth, as
often only a few iterations are performed.
The regularization parameter has been modelled as
λ0 “ λ˜maxpJTJq,
λi “ αλi´1, (3.18)
which makes the new parameters less dependant on the mesh, as the factor maxpJTJq
puts λ0 in the right order of magnitude. The parameter α determines the rate at
which λ decreases and should be chosen in the interval p0, 1q.
3.2.4 Jacobian calculation
The Jacobian J is a M ˆ N matrix where entry i, j represents the rate if change
in measurement in detector i due to a unit increase of activity in node j. Classi-
cally the perturbation method was used to find it, which relied on the individual
perturbation of each node followed by solving the forward model. For each such
iteration one column of J would be found. With this approach the computation of
J thus requires the forward model to be solved N times, which in most cases is
computationally expensive.
A more efficient way of calculating J is by using the adjoint formulation. It is
based on the principle that the fluence rate in node i due to the activity in node
j should be the same as the fluence in node i due to the same activity in node j.
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More simply put, a detector in node j will measure the same signal from a point
activity in node i as a detector in node i would measure from a point activity in
node j [47, 48].
Exploiting this the perturbation method can be employed to the detector nodes
only. With this approach one row instead of a column of J is found per iteration,
thus only requiring the forward model to be solved M times. The number of
measurements are usually much smaller than the number of nodes and this method
will thus be much more efficient the classic perturbation method.
3.2.5 Implementation
Similarly to the forward model the the inverse model has been implemented in
Matlab, once again using NIRFAST’s fluorescence routines as a template.
As the inverse model is based on the forward model the subject must be discretized
in the same manner. The one difference is that the activity distribution, which
now is unknown, is set to some initial guess. To speed up the optimization a
secondary, coarser, mesh is used to calculate the updates, while the fitting errors
are calculated on the original mesh.
As a measure of the progress of the optimization the relative change in squared
errors between subsequent iterations
pi “ δ
T
i´1δi´1 ´ δTi δi
δTi´1δi´1
(3.19)
is used. If pi ă 0 the sum of the squared errors has increased, in this case the
previous estimate Xi´1 is considered to be better than Xi and the iterations are
terminated and Xi´1 is returned. The other possibility is 0 ď pi ď 1, in this case
the new estimateXi is considered to be better than the previous one and is kept as
the current estimate. However if pi is small, below a certain threshold, it is likely
that future iterations will also results in minor improvements. As the forward
model has to be solved in each iteration this will result in a high computational
cost for small results. For this reason the iterations are terminated if pi is below a
certain threshold. In this implementation this threshold has been chosen as 0.02.
The reconsturcion algorithm starts with the calculation of the Jacobian matrix on
the fine mesh and it is then downsampled to the coarse mesh. This is only done
once since J is constant. At the start of each iteration the fitting error Y ´FpXiq
is calculated for the current estimate, at the first iteration the initial guess X0 is
used. After the error is found pi is calculated and the termination criteria are
checked, this is not performed on the first iteration. If no criteria is fulfilled the
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current estimate is downsampled to the coarse mesh and updated accordingly to
3.16. The new estimate is interpolated back to the fine mesh and the next iteration
is initiated, unless the iteration limit is reached. The inverse model is summarized
in algorithm 2.
Algorithm 2 Reconstruction scheme
1: J Ð dF
dX
2: JC Ð downsample J onto coarse mesh
3: λÐ λ˜maxpJTCJCq
4: iÐ 1
5: while i ď Iterations do
6: δi Ð Y ´ FpXiq
7: if i ą 1 then
8: pi Ð δ
T
i´1δi´1 ´ δTi δi
δTi´1δi´1
9: if pi ă 0 then
10: return Xi´1
11: else if pi ă tol then
12: returnXi
13: end if
14: λÐ αλ
15: end if
16: XCi Ð downsampleXi onto coarse mesh
17: H Ð JTCJC ` λI
18: ∆XCi`1 Ð H´1JTδi
19: XCi`1 ÐXCi `∆XCi`1
20: Xi`1 Ð interpolateXCi`1 onto fine mesh
21: iÐ i` 1
22: end while
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3.2.6 Post processing
Depending on the application it may be preferable to further process the recon-
structed activity Xˆ . If the activity is expected to be distributed smoothly over a
volume a smoothing filter might be useful. If, on the other hand, the activity is
expected to be very localized such filtering might not be suitable.
The estimate will typically contain a non-zero activity in each node, however often
many of the values will be very small. These values are rarely of interest and will
often considered as nodes with zero activity. For this reason it is often suitable to
threshold the data
XˆT piq “
#
Xˆpiq Xˆpiq ą T
0 Xˆpiq ď T. (3.20)
Although these values are rather insignificant individually, summed up they might
still constitute a significant fraction of the total reconstructed activity. For quanti-
tative measurements this must be considered. One way of dealing with this is to
scale the thresholded data so that it contains the same total activity as the original
estimate
Xˆ˚T “
ř
Xˆř
XˆT
XˆT . (3.21)
3.2.7 Hybrid reconstruction scheme
For reconstruction measurements in multiple spectral bands are often preferable
to a single one. This will however often require multiple measurements and ad-
ditional equipment. In some cases data might thus be limited to a single, often
rather large, spectral band. Reconstructions based on such a measurement might
perform poorly due to the inaccurate representation of the wavelength dependent
properties.
To improve performance in these cases a hybrid multi-spectral reconstruction al-
gorithm was implemented. In this hybrid model the measurement in the single
spectral band is assumed to be a sum of the emission of several smaller spectral
bands. These spectral bands are used in the forward model and the results from
each band is then summed form the predicted fluence rate in the original large
spectral band. In this way the wavelength dependence of the optical properties are
represented during the reconstruction.
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3.3 Validation
As several assumptions and approximations are used to formulate the models it is
important to verify them.
3.3.1 Continuous slowing down approximation
As earlier mentioned the deceleration of β-particles in a medium is stochastic.
In this model the continuous slowing down approximation is used which is a an
attempt to describe the average behaviour. It is a well known fact that in general
fpErXsq ‰ ErfpXqs
if f is non-linear. This is relevant since the CSDA basically yields the expected
value of the velocity and the amount of Cerenkov radiation emitted depends non-
linearly on it. It is thus not certain that the CSDA plugged into the Frank-Tamm
theory yields accurate results.
To verify the validity of this assumption the results from the CSDA were compared
to a Monte Carlo simulation of electron transport. More importantly the Cerenkov
radiation calculated with both methods was compared. The comparison where
made in the case of a singe point of activity within an infinite medium. The
Monte Carlo simulation takes more interactions into account than the CSDA. It
also accounts for the scattering of the β-particles and is considered a very accurate
model.
The idea of a hybrid model was presented by Hu et al. [7]. In their study it was
concluded the its performance was shown comparable to a multi-spectral model.
3.3.2 NIRFAST SPN
The SPN approximations are known to be corrections to the well-established dif-
fusion approximation. In cases where the diffusion approximation works well it
is thus fair to assume that higher order SPN methods also should perform well.
In these cases higher order methods are not really of interest as the diffusion ap-
proximation will be preferable due to lower computational cost. In cases where
the diffusion model does not hold it is however of interest to assess the perfor-
mance of higher order methods. In order to determine which approximation to
use a comparison between the SP1 ´ SP7 methods and Monte Carlo simulations
for different optical properties was performed.
The setting of the simulation was a single, isotropic, point source in an infinite
medium with constant optical properties. The simulations were performed with
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µa ranging from 0.001-0.16 mm´1 and µs ranging from 20-60 mm´1 while the
anisotropy factor was kept constant at g “ 0.95. Another reason for this validation
was to verify NIRFAST’s implementation.
3.3.3 Forward model
One of the main goals with this work was to present a forward model for the
propagation of Cerenkov radiation. A forward model has been presented but it
has to be verified to see that it actually describes the propagation of Cerenkov
radiation.
Two types of validation were performed for the forward model. The spectra of the
emitted Cerenkov radiation from subjects with known expected outcomes were
simulated. This was done for a completely transparent subject where the inherent
Cerenkov spectrum, λ´3 is expected and in a soft tissue subject. The other vali-
dation was an attempt to recreate the experimental measurements from phantoms
measurements.
3.3.4 Inverse model
The inverse model presented is basically a fitting of the forward model to mea-
sured data. The performance of the inverse model will thus heavily depend on
the accuracy of the forward model. The other part of the inverse model is the
optimization algorithm and the regularization, which both impacts the results.
Reconstructions has been performed on simulated data, where measurements were
generated as
Y “ FpXq
for an activity distribution of choice. In this case the subject was chosen as a
2ˆ 2ˆ 2 cm cube with the soft-tissue properties given by figure 2.1. The activity
distribution was chosen as a sphere with radius 3 mm with its center located 5 mm
from the centre of one of the subjects sides.
Reconstruction was also performed on data from an in vitro phantom measure-
ment. The purpose of these tests were to show the potential of the models and no
quantification of their accuracy has been attempted.
To assess the performance of the optimization the absolute relative error
ε “ |Y ´ FpXˆq|
Y
(3.22)
was considered. As this is a vector valued quantity its mean, εmean, and maximum
value, εmax, were chosen to represent it.
34
3.4. EXPERIMENTAL SET-UP AND EQUIPMENT METHODS
3.4 Experimental set-up and equipment
An in vitro study was conducted to test the performance of the presented models.
3.4.1 Phantoms
For the in vitro studies block shaped phantoms measuring 9ˆ3ˆ2 cm were used.
The phantoms were made out of epoxy resin. In order to cause the phantoms to
scatter light different concentrations of TiO2 were mixed in, as well as toner ink
for absorption. The phantoms were developed during a thesis project assessing
the imaging potential of Cerenkov emission [49]. Through the phantoms holes
were drilled, in which silicone tube filled with radioactive fluid was fitted, acting
as the activity distribution for the measurements.
In the experiments three different phantoms where used, labelled B3, C3 and D3.
They all had the same scattering properties but increasing absorption coefficients.
The optical properties of phantom B3 is shown in figure 3.1. The epoxy resin, and
thus the phantoms, has a refractive index of 1.54, which will produce a stronger
Cerekov emission than most tissues. The phantoms were based on the ones used
in [50], where the anisotropy factor was found to be about g “ 0.75.
Figure 3.1: Optical properties of phantom B3. The other phantoms used, C3 and
D3, had the same scattering coefficient but two and four times higher absorption
respectively.
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3.4.2 Radioactive isotopes
Two different β-emitting radioisotopes were used in the phantom measurements.
18F, which is one of the most commonly used isotopes in PET, and 66Ga. These
isotopes has rather different characteristics, 18F emits relatively low energy positrons
and has a half-life of about 110 minutes. 66Ga on the other hand emits positrons
with high energies and has a half-life of roughly 9.5 hours. The energy spectrum
for the two isotopes are shown in figure 3.2. From the spectra it can be seen that
Figure 3.2: Unnormalized spectra for the energy of emitted positrons from 18F
and 66Ga [31]. The dashed line indicated the threshold for Cerenkov emission in
soft tissue.
roughly half of the decays from 18F results in the emission of Cerenkov radiation
while this number is significantly higher for 66Ga.
From a clinical perspective 18F has the nice property of delivering a rather small
dose to the subject, due to its low energy emission and fast decay. 66Ga will
produce a strong signal over a longer period of time. Properties which could be
very useful in preclinical studies.
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3.4.3 Camera
The detection device used in the experimental measurements was a front illumi-
nated Andor iKon-M 934. This is a CCD with 1024ˆ 1024 pixels of size 13ˆ 13
µm [51].
This camera was used both for the detection of Cerenkov emission and white-light
images of the set-up. During measurements the camera was cooled to -85˝ C to
reduce the influence of noise caused by dark currents.
The quantum efficiency of this camera is shown in figure 3.3. As both of the
radionuclides used in the studies were positron emitters a significant amount of
511 keV gamma photons were produced from annihilations. While the camera is
insensitive to these photons some of them will still be registered. These detected
gamma photons will produce a very strong signal due to their very high energy.
The strongest signal in the raw image acquired will typically be the 511 keV
gamma photons and in order to extract the Cerenkov emission some processing of
the data is required.
Figure 3.3: Quantum efficiency of the Andor iKon-M 934 CCD used for the mea-
surement [51].
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3.4.4 Pre-processing of measurements
To increase the sensitivity of the Cerenkov measurements the acquired image was
subjected to 4 ˆ 4 pixel binning in the 66Ga experiment and 8 ˆ 8 in the 18F
measurement. Following the binning a 9ˆ 9 pixel median filter was employed to
remove the signal from the gamma photons.
Due to the cooling of the system the background noise in the measurements was
close to constant. This constant background was subtracted from the measurement
and the resulting image were normalized with the exposure time. Finally any
negative pixel values resulting from the background subtraction was removed.
3.4.5 Experimental set-up
To prevent external light from polluting the measurements the phantoms were
placed in a box with the camera fitted through the top. To eliminate as much light
from the outside as possible the box was covered by black fabric and cardboard
sheets.
Inside the box a light diode was mounted to enable white-light images to be taken
of the subject after the box had been sealed. A 10 minute exposure time were used
for the Cerenkov measurements.
In the 66Ga experiment the three phantoms B3, C3 and D3 was placed side by
side. The tube containing the 66Ga was fitted through all of them at a depth of 8
mm.
In the 18F experiment only phantom B3 was used. In this case the tube was located
at a depth of 4.5 mm. This phantom was also imaged by a combined PET and CT
scan.
Figure 3.4: To the left, white light image of the 18F experiment. To the right, the
corresponding Cerenkov image of the phantom.
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4.1 Continuous slowing down approximation
The Monte Carlo data for the deceleration of electrons was compared to the CSDA
to verify that the stopping power used is reasonable. Calculations of the Cerenkov
emission based on the two different data sets were also compared.
4.1.1 Energy distribution
The Monte Carlo simulations yielded the probability distribution of the electron
energy at distances ranging from 0.1-5 mm from the decay. This distribution for
electrons with an initial energy of 1 MeV is displayed in figure 4.1. On top of
the distribution the results from the CSDA is plotted, and it seems to follow the
high probability ridge fairly well. As the CSDA is based on the average stopping
Figure 4.1: Probability distribution for 1 MeV electrons in soft tissue from the
Monte Carlo simulation. Note the logarithmic scale.
power it could be of interest to see how the average electron decelerates based on
the Monte Carlo distribution. This comparison is shown in figure 4.2. Clearly
there are differences between the results based on the CSDA and the Monte Carlo
simulation.
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Figure 4.2: Expected electron energy versus distance travelled for 1 MeV elec-
trons.
4.1.2 Cerenkov yield
The difference between the Monte Carlo and the CSDA data should result in some
differences in the calculated Cerenkov emission. A comparison of the emitted
Cerenkov radiation per path length for 1 MeV electrons is shown in figure 4.3.
The differences from 4.2 seems to be well reflected in the Cerenkov emission.
The total energy emitted from a 1 MeV electron, that is the integral of the curves
in 4.3, is also important to compare. The total Cerenkov energy emitted from
electrons with initial energy ranging from 0.1-1 MeV was compared. The results
are shown in figure 4.4. Despite the differences previously seen the total energy
calculated with CSDA deviates less than 5 % from the Monte Carlo calculation.
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Figure 4.3: Expected Cerenkov emission per path length from 1 MeV electrons.
Figure 4.4: Total emitted Cerenkov radiation from electrons with initial energy
ranging from 0.1-1 MeV. The dashed curves indicates the 5 % deviation region
from the Monte Carlo data.
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4.2 Nirfast SPN
The results from one of the simulations comparing the SPN methods to Monte
Carlo is shown in figure 4.5. It is seen that the results from the SP3 method be-
Figure 4.5: Fluence rate as a function of distance from a point source in an infinite
medium. The medium has the optical properties µa “ 0.02 mm´1, µs “ 20 mm´1
and g “ 0.95.
haves strangely close to the source, which occurred in several of the simulations.
The cause for this behaviour was never isolated but numerical instabilities in the
solution of 3.1 or some flaw in NIRFAST’s implementation are possible expla-
nations. Apart from this anomaly these results confirms the expected behaviour
of the SPN approximations. SP1 does not perform as well as the higher order
approximations at short distances while at longer distances all methods seem to
converge.
Due to the unexpected behaviour the SP3 method were discarded. From the simu-
lations it was found that the SP5 and SP7 methods produce similar results. Since
the computational cost is significantly higher for the SP7 approximation, the SP5
method was considered to be the better of the two.
The dependence of the performance on the optical properties for the SP1 and SP5
methods are shown in figure 4.6. In this figures the absolute relative error between
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them and the Monte Carlo simulations are displayed at the distances 1 and 2 mm
from the source. It should be noted that these plots are interpolations from only
Figure 4.6: Absolute value of the relative error between SP1, SP5 and the Monte
Carlo simulation at 1 and 2 mm distance from the source.
16 original data points. They should thus not be used to assess the error of the
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methods for certain optical properties. The purpose of them here is to give an
indication of the general behaviour of the approximations compared to a Monte
Carlo simulation. In figure 4.6 it can be seen that error for SP5 varies rather slowly
and seems to follow a pattern. The error for SP1 on the other hand is a bit erratic.
At farther distances from the source the difference between SP1 and SP5 is small,
as indicated by figure 4.5, and the corresponding plots for these distances will thus
be similar.
The conclusion from these simulations are that SP5 in general seems to produce
slightly better and more consistent results than SP1. The SP1 method still seems
fairly accurate and it is not obvious whether the extra computations required for
SP5 are worthwhile.
4.3 Forward model
The forward model was tested by simulating its spectrum in two different subjects.
The emission predicted by it was also compared from the phantom experiments.
4.3.1 Simulations
The matrix generation in NIRFAST does not support completely transparent me-
dia. For the transparent simulation a close to transparent medium was used in-
stead. This medium was chosen to have parameters g “ 1 and µa “ µs “ 10´10
mm´1, which in practice eliminates the effects of scattering and implies an av-
erage distance between absorption events of 107 metres. The spectrum obtained
from the forward model in this medium is shown in figure 4.7. As the absolute
intensity of this spectrum is dependant on geometry, activity distribution and also
on β-source the spectrum has been normalized. The spectrum calculated with the
forward model matches the expected spectrum, which indicates that the Cerenkov
source representation and implementation is accurate.
In the soft tissue-like medium there is no explicitly known expected spectrum to
compare with. A similar simulation was performed by Spinelli et. al [52], and
while the optical properties used in their simulation was not presented the general
shape of the spectrum should be similar. The spectrum in this medium calculated
with both the SP1 and SP5 method is shown in figure 4.8. In this simulation SP1
and SP5 thus produced slightly different results. The general shape of the acquired
spectrum is however similar to the one presented in [52]. It also corresponds well
to the absorption given in figure 2.1.
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Figure 4.7: Normalized spectrum of the Cerenkov radiation in a transparent
medium. The black dots represents the values calculated with the forward model.
The solid blue curve is the expected λ´3 spectrum.
Figure 4.8: Cerenkov spectrum from a medium with soft tissue properties.
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4.3.2 Experimental
The pre-processed image acquired from the 66Ga phantom experiment is shown
in figure 4.9 along with the forward simulation for the phantoms. The intensity
Figure 4.9: To the left, measured intensity from the 66Ga phantom experiment. To
the right, simulated intensity from the forward model.
was extracted along the black lines to compare the measurements to the forward
model. From the extracted measured intensity outliers were removed and smooth-
ing with a mean value filter was performed. Both intensities were normalized to
have maximum value 1, the result is shown in figure 4.10. The intensities in phan-
toms B3 and C3 seems to be well described by the forward model while the results
in D3 does not quite agree. The width profiles of the emission in the phantoms is
also fairly well described by the forward model.
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Figure 4.10: Measured and simulated intensities from the 66Ga phantom exper-
iment. Solid curves are data from the forward model and dashed curves are the
measurements. In the lower plot, the red, black and blue curves are associated
with phantoms B3, C3 and D3 respectively.
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4.4 Inverse model
Reconstruction of the activity distribution was performed on simulated data as
well as on the measurements from the 18F and 66Ga experiments. In the latter only
phantom B3 was used as it provided the strongest signal.
4.4.1 Simulation
The subject used for the simulated reconstruction is shown in figure 4.11.
Figure 4.11: Scatter-plot of the subject used for the simulated reconstruction. The
small blue dots are nodes with zero activity and the large red circles represent the
spherical cluster of nodes with non-zero activity.
The reconstructed activity as well as the actual activity from the simulation along
a line through the center of the sphere of activity is shown in figure 4.12. The
spatial distribution of the reconstructed activity is shown in figure 4.13.
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Figure 4.12: Reconstructed activity from the simulated data. The blue curve is
the raw reconstructed activity, while the red curve is the reconstruction after a
threshold.
The relative error of the optimization had a mean of εmean “ 2.9 % and a maxi-
mum value of εmax “ 7.6 %. Indicating that the reconstruction fits the measure-
ments well.
The raw reconstructed activity produces a small fitting error, indicating that it is
close to an optimum of 2.34, it is however not close to the true activity. From the
results in figure 4.12 and 4.13 it is clear that the threshold can improve the recon-
struction significantly. It should be noted that in this simulation the threshold was
chosen to match the known activity, in a real case where the activity distribution
is unknown the problem of choosing a threshold will not be so simple.
4.4.2 Experimental
As the models were not calibrated to the equipment no comparison in the abso-
lute magnitude of the activity was possible. The measurements on the phantoms
were performed without any filters and no multi-spectral data was therefore ac-
quired. For this reason the hybrid reconstruction algorithm was used for these
reconstructions.
To visualize the reconstructed activity a projection of the activity density onto the
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Figure 4.13: Reconstructed activity in a slice from the simulated data. The black
curve indicates the boundary of the true activity distribution. The upper image
displays the raw reconstructed activity and the bottom one the reconstruction after
the threshold.
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sides of the phantoms has been used. The projections shown are the integral of
the activity along the axes of the phantom
Pside “
ż
Ady Pfront “
ż
Adx Ptop “
ż
Adz.
From the 66Ga measurement the activity in phantom B3 was reconstructed. To
reduce the computational time only a 3 ˆ 3 ˆ 2 cm part, centred on the activity
containing tube, was reconstructed. The results from this reconstruction is shown
in figure 4.14.
Figure 4.14: To the left, projections of the reconstructed activity in phantom B3
from the 66Ga experiment. To the right, the projections of the tubes location.
The relative error of this optimization is characterized by εmean “ 10.9 % and
εmax “ 31.1 %. These errors are rather large, which could be due to a local
minima being found or noise in the measurements.
The measurements from the 18F were also reconstructed in a 3ˆ 3ˆ 2 cm part of
the phantom. The results from this reconstruction is displayed in figure 4.15.
The mean and maximum relative error for this optimization was εmean “ 0.3
% and εmax “ 1.5 %. The reconstructed activity thus fits the measurements very
well. These results indicate that not only the Cerenkov emission is being described
by the reconstructed activity but also the measurement noise.
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Figure 4.15: To the left, projections of the reconstructed activity from the 18F
experiment. To the right, the projections of the tubes location.
The PET/CT image of the phantom is shown in figure 4.16. PET is able to recon-
struct the distribution of the 18F within the tube with a high accuracy.
Figure 4.16: PET/CT image of phantom B3 containing 18F. In these images it is
the upper channel which has been used for the Cerenkov imaging.
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5 DISCUSSION
5.1 Approximations
5.1.1 Continuous slowing down approximation
There were some differences in the predicted Cerenkov emission between CSDA
and the Monte Carlo simulation. However the two methods did agree on the dis-
tance at which the Cerenkov emission ceased, roughly 4 mm for 1 MeV elec-
trons. The total amount of Cerenkov radiation predicted were also similar, with
the CSDA results deviation less than 5 % from the Monte Carlo simulation. The
only significant difference were thus that CSDA predicted a lower emission close
to the decay and a higher emission farther away. These results were based on
decays in a single point and in practice with a spread out activity distribution this
difference should be less prominent.
From these results it was concluded that CSDA yields a sufficiently accurate de-
scription of the electron deceleration for this work. However these results also
indicate that replacing the CSDA with Monte Carlo simulations might improve
the spatial distribution of the Cerenkov radiation. In that case the forward model
would be more accurate and could potentially improve the spatial resolution of
the inverse model.
5.1.2 Isotropic Cerenkov emission
The assumption of an isotropic Cerenkov source has not been individually veri-
fied. It is fairly common in medical optics to model directed sources as isotropic
ones, with some modifications, due to the strong scattering in tissue. The alter-
native would be to model the directional dependence of the source, which in the
case of CLI would require the paths of β-particles to be accurately described. Due
to the stochastic nature of their interactions with a medium this would most likely
require a Monte Carlo method to be employed. On top of that to capture the ef-
fects of the directional source the RTE would have to be solved for a directionally
dependent radiance. This would increase the computational cost for solving the
model to increase drastically.
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5.1.3 NIRFAST SPN
As expected the higher order methods gave better results than lower order, with
the exception of SP3 which deviated significantly close to the source. The reason
for this unexpected behaviour was never found but is likely due to numerical in-
stabilities. As earlier mentioned SP5 and SP7 produces very similar results and
due to the higher computational cost SP7 was neglected. Between the remaining
SP1 and SP5 methods there were noticeable differences in performance, with SP5
performing slightly better. The cost of SP5 is that the stiffness matrix is of size
3N ˆ 3N compared to the N ˆN for SP1. This causes the forward model to be
solved slower since both matrix generation and equation solving is affected. This
difference is further amplified in the inverse model where the forward model is
solved multiple times.
Whether a higher order method is worthwhile or not will depend on the applica-
tion. In the simulations and phantom experiments presented here the properties of
the subjects are well controlled and higher order methods will likely yield better
results. In more complicated cases, as in vivo studies, where there is uncertain-
ties in optical properties the limiting factor might not be the order of the RTE
approximation. In such cases higher order methods might thus be a wasted effort.
5.2 Results
5.2.1 Forward model
The spectra produced from the forward model were in good agreement with the
expected results. The well-known λ´3 Cerenkov spectrum was accurately repro-
duced when the emission occurred in a transparent medium. For the tissue-like
medium no reference spectrum was available but the optical properties in figure
2.1 seems to be well reflected. The tissue spectrum also has a similar shape as the
one presented in [52].
The 66Ga experimental results showed that the emission in phantoms B3 and C3
could be accurately reproduced with the forward model. In phantom D3 the sim-
ulated intensity deviated with about 25 % from the measurement. However the
measurements from this phantom was weaker than the others and should thus be
considered as the least reliable.
The width profile of the measured radiation was also fairly well reproduced by
the forward model. Common for all three phantoms is that the measured value far
from the peak intensity is slightly higher, this is likely due to noise or other effects
not accounted for. From the measured image 4.9 it is clear that there is non-zero
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measurements far away from the activity. The discrepancy is larger at the far end
in figure 4.10, i.e at distance 25-30 mm. This is the end close to the boundary of
the phantom which could introduce additional errors due to higher reflection than
expected.
5.2.2 Inverse model
In the simulated test of the inverse model the measurements used to reconstruct
were simulated intensities from the forward model. In this case it might seem
like a perfect match would be achievable, since there obviously exist an activity
distribution which will yield a zero fitting error. It is however not computationally
feasible to use the intensities in all of the nodes in subject. This would not repre-
sent any realistic case either since actual measurements typically are external or
possibly limited to a few internal locations. In this simulation 25 detector nodes
were used, all located on the same side of the subject. From this limited amount
of measurements 9261 unknowns are to be reconstructed, which as earlier men-
tioned will be an ill-posed problem. All things considered a perfect reconstruction
is thus not expected.
The raw reconstructed activity was not that similar to the true activity. With the
threshold operation 3.21 an activity distribution close to the true one was recov-
ered. It should be noted that the threshold used were determined with perfect
knowledge of the true activity distribution. It does however show that with perfect
measurements and threshold it is possible to achieve an accurate reconstruction.
The reconstructions based on the experimental measurements did not agree with
the known locations of the radioactive isotopes. The fitting errors for them were
however small, indicating that they were in fact close to optimums of 2.34. This
highlights the non-uniqueness of the problem, even if these activity distributions
are decent candidates for the minimization, they are still not close to the desired
solutions. There are several possible explanations to this behaviour. Mismatch be-
tween true and modelled optical properties might distort the results. The quality
of the measurements are also very important, as the Cerenkov radiation is rather
weak noise will have a large impact. This is probably the cause for the recon-
structed activity in the 66Ga reconstruction to be mainly located in two clusters. It
has been shown that multi-spectral data should improve reconstructions [53]. The
regularization of the problem also affects the reconstruction and it is possible that
a different regularization strategy could yield better results.
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5.3 Model Limitations
While the theory presented allows for a spatially dependant refractive index the
implementation using a Cerenkov point source function only applies to the case
where the refractive index does not change. This generalization would be straight-
forward to implement, but will be more computationally costly as the source
would have to be calculated for each node. This would especially affect the Jaco-
bian calculation, where a source has to be calculated for each detector. In cases
with constant refractive index the current implementation is thus preferable and
these have been the only cases considered in this work.
In the current implementation detectors are only allowed to be located on the
boundary of the subject. This was done to prevent detectors to be placed internally
by mistake, as CLI classically is based on external measurements. It is however
not unthinkable that internal measurements could be interesting in some settings.
This modification would be very simple to make, as the forward model already
calculates the fluence rate of light internally. The change would thus consist of
allowing internal nodes to be marked as detectors and allow their nodal value to
be extracted. Some additional boundary conditions between the subject and the
detection device might also be required.
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CONCLUSIONS
A forward model for the emission and propagation of Cerenkov radiation from
β-particles has been formulated based on the theory of Frank and Tamm and ra-
diative transport. This model maps an activity distribution of a known radionu-
clide within a subject, with known optical properties, onto the fluence rate within
it. Notably the exiting radiation is calculated on the boundary, which allows for a
direct comparison to external measurements.
The Cerenkov emission has been calculated using the continuous slowing down
approximation for β-particles in tissue. The β-particles has been assumed to in-
duce Cerenkov emission in all direction equally. The propagation of the emitted
radiation has been described by the well-established radiative transport equation
with partially reflective boundary conditions. In order to solve the radiative trans-
port equation the simplified spherical harmonics approximations has been em-
ployed. Throughout this work the SP5 method were employed.
From the forward model an inverse model has been developed. This model esti-
mates the activity distribution within a subject given measurements of the radia-
tion and optical properties. The inverse model is formulated as an optimization
problem where the difference between the forward model and the measurements
should be minimized. As the optimization problem typically is ill-posed regular-
ization is required to stabilize it. To solve the optimization a Levenberg-Marquardt
algorithm has been used, which inherently regularizes the problem.
A finite element method has been employed to solve the radiative transport equa-
tion in the forward model. The stiffness matrix required for this approach has been
calculated using routines from NIRFAST. All implementation has been performed
in Matlab, following the structure of NIRFAST’s fluorescence routines.
Verification of assumptions and the models has mainly been performed through
simulations and comparisons to Monte Carlo results. Two minor in vitro stud-
ies was also conducted for experimental validation. Results for the forward model
were in general good and seemed to yield a fairly accurate description of the prop-
agation of Cerenkov radiation. The inverse model produced acceptable results on
simulated data but for the experimental data the results were not quite satisfactory.
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OUTLOOK
Experimental studies have been very limited during this work and obviously a
large-scale, systematic study would be very interesting. Things to investigate
could include the resolution of the reconstructed activity, which would require the
system to be calibrated to the forward model. Experimental reconstruction based
on several spectral bands could also be of interest, as it may improve performance.
While the forward model produced good results it could of course be improved.
As previously discussed it would be interesting to see the effects of a Monte Carlo
based Cerenkov source term. The results of the inverse model was a bit disap-
pointing and it will likely need to be improved before being used experimentally.
Different regularization or optimization strategies could be of interest. As the in-
verse model is closely related to the forward model it is also highly likely that any
improvements of the forward model will result in a better inverse model.
Although the forward model is working, it has limited practical use. If the inverse
model could be modified to produce satisfactory reconstructions the performance
of CLI as a method could be assessed. Such studies would thus not focus on the
particular implementations presented in this work but rather the performance of
CLI for different applications. Examples of such studies could include evaluation
of xenograft tumour models and radiation therapy dose assessment, in particular
from electron emitting compounds. The current model could also be extended to
handle hybrid optical imaging modalities, such as Cerenkov excited fluorescence
imaging.
58
AUTHOR REFLECTION
This has been the by far largest and most complex scientific project I have ever
committed myself to. It has in many ways been challenging and I have had to use
a wide range of my knowledge during this work. I have also gained a lot of new
knowledge, mostly regarding the field of optical imaging and related methods.
I do, however, believe that the most valuable lesson from this work will be the
experience of working with the different parts of a large scale project, like this one.
The general approach and method practiced in this project will almost certainly
be of great use to me in future assignments.
The exposure to a scientific environment, where I have been able to partake in
discussions has been enlightening and given me insight into the how research is
conducted at a high level. For me, as a person with a genuine interest in science
and technology, it has also been a great deal of fun.
To summarize I am very happy with the project, I have learned a lot and perhaps
most importantly gained experience in working with a real-life problem. I am
grateful to have been given this opportunity and I am confident that it has been a
worthwhile experience.
59
ACKNOWLEDGEMENTS
I would like to thank the members of the biophotonics group at the division of
atomic physics, department of physics, at LTH for providing a friendly and stimu-
lating working environment. I am very grateful to have been given the opportunity
to be a part of this group and work together with you.
I am also very grateful to Professor Stefan Anderson-Engels for showing me the
beauties (and the horrors) of optical imaging in the first place. It was your teaching
that sparked my interest for the subject and without it I may never have written
this paper.
A special thanks to Erik Larsson for providing Monte Carlo simulations for the
electron transport.
My deepest gratitude goes to Johan Axelsson for giving me this opportunity and
guiding me through it, you have truly been an outstanding supervisor.
Finally, from the bottom of my heart, I would like to thank my family for their
never-ending support and encouragement.
60
BIBLIOGRAPHY
[1] M. L. James and S. S. Gambhir. A molecular imaging primer: modalities,
imaging agents, and applications. Physiol. Rev., 92:897–965, 2012.
[2] N. Deshpande, A. Needles, and J. K. Willmann. Molecular ultrasound imag-
ing: current status and future directions. Clinical Radiology, 65(7):567–581,
2010.
[3] R. Robertson, M. S. Germanos, C. Li, G. S. Mitchell, S. R. Cherry, and M. D.
Silva. Optical imaging of Cerenkov light generation from positron-emitting
radiotracers. Physics in Medicine and Biology, 54(16):N355, 2009.
[4] H. Ross. Measurement of β-emitting nuclides using Cerenkov radiation.
Analytical Chemistry, 41(10):1260–1265, 1969.
[5] Y. Xu, E. Chang, H. Liu, H. Jiang, S. S. Gambhir, and Z. Cheng. Proof-of-
Concept Study of Monitoring Cancer Drug Therapy with Cerenkov Lumi-
nescence Imaging. Journal of Nuclear Medicine, 53(2):312–317, 2012.
[6] Z. Hu, J. Liang, W. Yang, W. Fan, C. Li, X. Ma, X. Chen, X. Ma, X. Li,
X. Qu, J. Wang, F. Cao, and J. Tian. Experimental Cerenkov luminescence
tomography of the mouse model with SPECT imaging validation. Opt Ex-
press, 18(24):24441–24450, 2010.
[7] Z. Hu, X. Ma, X. Qu, W. Yang, J. Liang, J. Wang, and J. Tian. Three-
dimensional Noninvasive Monitoring Iodine-131 Uptake in the Thyroid Us-
ing a Modified Cerenkov Luminescence Tomography Approach. PLoS ONE,
7(5):e37623, 2012.
[8] C. Li, G. S. Mitchell, and S. R. Cherry. Cerenkov luminescence tomography
for small-animal imaging. Optics Letters, 35(7):1109 – 1111, 2010.
[9] H. Liu, G. Ren, Z. Miao, X. Zhang, X. Tang, P. Han, S. S. Gambhir, and
Z. Cheng. Molecular Optical Imaging with Radioactive Probes. PLoS ONE,
5(3), 2010.
[10] R. Robertson, M. S. Germanos, M. G. Manfredi, P. G. Smith, and M. D.
Silva. Multimodal imaging with (18)F-FDG PET and Cerenkov lumines-
cence imaging after MLN4924 treatment in a human lymphoma xenograft
model. Journal of Nuclear Medicine, 52(11):1764–1769, 2011.
[11] G. S. Mitchell, R. K. Gill, D. L. Boucher, C. Li, and S. R. Cherry. Cerenkov
luminescence tomography for small-animal imaging. Philosophical Trans-
actions of the Royal Society A: Mathematical, Physical and Engineering
Sciences, 369(1955):4605–4619, 2011.
61
[12] A. E. Spinelli, C. Kuo, B. W. Rice, R. Calandrino, P. Marzola, A. Sbarbati,
and F. Boschi. Multispectral Cerenkov luminescence tomography for small
animal optical imaging. Opt. Express, 19(13):12605–12618, 2011.
[13] A. Ruggiero, J. P. Holland, J. S. Lewis, and J. Grimm. Cerenkov Lu-
minescence Imaging of Medical Isotopes. Journal of Nuclear Medicine,
51(7):1123–1130, 2010.
[14] J. Zhong, C. Qin, X. Yang, S. Zhu, X. Zhang, and J. Tian. Cerenkov Lumi-
nescence Tomography for In Vivo Radiopharmaceutical Imaging. Interna-
tional Journal of Biomedical Imaging, 2011(Article ID 641618), 2011.
[15] S. Y. Jeong, M. H. Hwang, J. E. Kim, S. Kang, J. C. Park, J. Yoo, J. H.
Ha, S. W. Lee, B. C. Ahn, and J. Lee. Combined Cerenkov luminescence
and nuclear imaging of radioiodine in the thyroid gland and thyroid cancer
cells expressing sodium iodide symporter: initial feasibility study. Endocr
J, 58(7):575–583, 2011.
[16] A. E. Spinelli, M. Ferdeghini, C. Cavedon, E. Zivelonghi, R. Calandrino,
A. Fenzi, A. Sbarbati, and F. Boschi. First human Cerenkography. Journal
of Biomedical Optics, 18(2):020502–020502, 2013.
[17] H. Liu, C. M. Carpenter, H. Jiang, G. Pratx, C. Sun, M. P. Buchin, S. S.
Gambhir, L. Xing, and Z. Cheng. Intraoperative Imaging of Tumors Us-
ing Cerenkov Luminescence Endoscopy: A Feasibility Experimental Study.
Journal of Nuclear Medicine, 53(10):1579–1584, 2012.
[18] J. P. Holland, G. Normand, A. Ruggiero, J. S. Lewis, and J. Grimm. In-
traoperative Imaging of Positron Emission Tomographic Radiotracers Using
Cerenkov Luminescence Emissions. Molecular Imaging, 10(3):177 – 186,
2011.
[19] N. L. Ackerman and E. E. Graves. The potential for Cerenkov luminescence
imaging of alpha-emitting radionuclides. Physics in Medicine and Biology,
57(3):771, 2012.
[20] D. L. J. Thorek, A. Ogirala, B. J. Beattie, and J. Grimm. Quantitative imag-
ing of disease signatures through radioactive decay signal conversion. Na-
ture Medicine, 19(10):1345–1350, 2013.
[21] R. S. Dothager, R. J. Goiffon, E. Jackson, S. Harpstrite, and D. Piwnica-
Worms. Cerenkov Radiation Energy Transfer (CRET) Imaging: A Novel
Method for Optical Imaging of PET Isotopes in Biological Systems. PLoS
ONE, 5(10):e13300, 2010.
62
[22] M. A. Lewis, V. D. Kodibagkar, O. K. Öz, and R. P. Mason. On the
potential for molecular imaging with Cerenkov luminescence. Opt. Lett.,
35(23):3889–3891, 2010.
[23] C. Ran, Z. Zhang, J. Hooker, and A. Moore. In Vivo Photoactivation Without
“Light” Use of Cherenkov Radiation to Overcome the Penetration Limit of
Light. Mol Imaging Biol, 14(2):156–162, 2011.
[24] J-L. Demers, S. C. Davis, R. Zhang, D. J. Gladstone, and B. W. Pogue.
Cˇerenkov excited fluorescence tomography using external beam radiation.
Opt. Lett., 38(8):1364–1366, 2013.
[25] J. Axelsson, S. C. Davis, D. J. Gladstone, and B. W. Pogue. Cerenkov emis-
sion induced by external beam radiation stimulates molecular fluorescence.
Medical Physics, 38(7):4127–4132, 2011.
[26] J. V. Jelley. Cˇerenkov Radiation and its applications. United Kingdom
Atomic Energy Authority, 1958.
[27] L. Fülöp and T. Biró. Cherenkov radiation spectrum. International Journal
of Theoretical Physics, 31(1):61–74, 1992.
[28] G. B. Collins and V. G. Reiling. Cˇerenkov Radiation. Phys. Rev., 54:499–
503, 1938.
[29] J. A. Rich, R. E. Slovacek, and F. J. Studer. Cˇerenkov Radiation from a Co60
Source in Water. J. Opt. Soc. Am., 43(9):750–750, 1953.
[30] E. J. Konopinski. Beta-Decay. Rev. Mod. Phys., 15:209–245, 1943.
[31] M. G. Stabin and C. Q. P. L. da Luz. New Decay Data For Internal and
External Dose Assessment. Health Phys., 83(4):471–475, 2002.
[32] S. M. Seltzer and M. J. Berger. Evaluation of the collision stopping power
of elements and compounds for electrons and positrons. The International
Journal of Applied Radiation and Isotopes, 33(11):1189 – 1218, 1982.
[33] S. M. Seltzer and M. J. Berger. Procedure for calculating the radiation stop-
ping power for electrons. The International Journal of Applied Radiation
and Isotopes, 33(11):1219 – 1226, 1982.
[34] M. J. Berger, J. S. Coursey, M. A. Zucker, and J. Chang. ESTAR,
PSTAR, and ASTAR: Computer Programs for Calculating Stopping-Power
and Range Tables for Electrons, Protons, and Helium Ions (version 1.2.3).
[Online] Available: http://physics.nist.gov/Star [2013-08-29]. National In-
stitute of Standards and Technology, Gaithersburg, MD.
63
[35] T. Tomimasu. Evidence for Positron-Electron Differences in Scintillation
Response and Stopping Power. Phys. Rev., 138:A268–A272, 1965.
[36] F. Rohrlich and B. C. Carlson. Positron-Electron Differences in Energy Loss
and Multiple Scattering. Phys. Rev., 93:38–44, 1954.
[37] R. Nachabe, B. H. Hendriks, M. van der Voort, A. E. Desjardins, and H. J.
C. M. Sterenborg. Estimation of biological chromophores using diffuse op-
tical spectroscopy: benefit of extending the UV-VIS wavelength range to
include 1000 to 1600 nm. Biomed. Opt. Express, 1(5):1432–1442, 2010.
[38] S. L. Jacques. Optical properties of biological tissues: a review. Physics in
Medicine and Biology, 58(11):R37, 2013.
[39] L. C. Henyey and J. L.Greenstein. Diffuse radiation in the Galaxy. The
Astrophysical Journal, 1941.
[40] A. D. Klose and E. W. Larsen. Light transport in biological tissue based
on the simplified spherical harmonics equations. Journal of Computational
Physics, 220(1):441 – 470, 2006.
[41] E. W. Larsen, J. E. Morel, and J. M. McGhee. Asymptotic derivation of
the multigroup P1 and Simplified PN equations with anisotropic scattering.
1994.
[42] G. C. Pomraning. Asymptotic and variational derivations of the simplified
PN equations. Annals of Nuclear Energy, 20(9):623 – 637, 1993.
[43] R. T. Ackroyd, C. R. E. de Oliveira, A. Zolfaghari, and A. J. H. Goddard. On
a rigorous resolution of the transport equation into a system of diffusion-like
equations. Progress in Nuclear Energy, 35(1):1 – 64, 1999.
[44] J. Zhong, J. Tian, X. Yang, and C. Qin. Whole-Body Cerenkov Lumines-
cence Tomography with the Finite Element SP3 Method. Annals of Biomed-
ical Engineering, 39(6):1728–1735, 2011.
[45] M. Jermyn, H. Ghadyani, M. A. Mastanduno, W. Turner, S. C. Davis,
H. Dehghani, and B. W. Pogue. Fast segmentation and high-quality three-
dimensional volume mesh creation from medical images for diffuse optical
tomography. Journal of Biomedical Optics, 18(8):086007–086007, 2013.
[46] H. Dehghani, P. K. Yalavarthy M. E. Eames, S. C. Davis, S. Srinivasan, C. M.
Carpenter, B. W. Pogue, and K. D. Paulsen. Near infrared optical tomogra-
phy using NIRFAST: Algorithm for numerical model and image reconstruc-
tion. Communications in Numerical Methods in Engineering, 25:711–732,
2009.
64
[47] S. R. Arridge. Optical tomography in medical imaging. Inverse Problems,
15(2):R41, 1999.
[48] S. R. Arridge and J. C. Schotland. Optical tomography: forward and inverse
problems. Inverse Problems, 25(12):123010, 2009.
[49] E. Mellhammar. Performance Assessment of Cerenkov Emission Imaging.
Master’s thesis, Department of Physics and Department of Medical Radia-
tion Physics, Lund University, 2013. http://www.lunduniversity.
lu.se/o.o.i.s?id=24965&postid=4192067.
[50] J. Swartling, J. S. Dam, and S. Andersson-Engels. Comparison of Spatially
and Temporally Resolved Diffuse-Reflectance Measurement Systems for
Determination of Biomedical Optical Properties. Appl. Opt., 42(22):4612–
4620, 2003.
[51] Andor. http://www.andor.com/scientific-cameras/
ikon-ccd-camera-series/ikon-m-934. Accessed: 2014-02-03.
[52] A. E. Spinelli and F. Boschi. Optimizing in vivo small animal Cerenkov
luminescence imaging. Journal of Biomedical Optics, 17(4):4–6, 2012.
[53] H. Dehghani, S. C. Davis, and B. W. Pogue. Spectrally resolved biolumines-
cence tomography using the reciprocity approach. Med. Phys., 35(11):4863–
71, 2008.
65
